Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Dual Targeting of Cell Wall Precursors by Teixobactin Leads to Cell Lysis.

Homma T, Nuxoll A, Gandt AB, Ebner P, Engels I, Schneider T, Götz F, Lewis K, Conlon BP.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6510-6517. doi: 10.1128/AAC.01050-16. Print 2016 Nov.

2.

Hidden Mode of Action of Glycopeptide Antibiotics: Inhibition of Wall Teichoic Acid Biosynthesis.

Singh M, Chang J, Coffman L, Kim SJ.

J Phys Chem B. 2017 Apr 27;121(16):3925-3932. doi: 10.1021/acs.jpcb.7b00324. Epub 2017 Apr 14.

3.

A new antibiotic kills pathogens without detectable resistance.

Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, Mueller A, Schäberle TF, Hughes DE, Epstein S, Jones M, Lazarides L, Steadman VA, Cohen DR, Felix CR, Fetterman KA, Millett WP, Nitti AG, Zullo AM, Chen C, Lewis K.

Nature. 2015 Jan 22;517(7535):455-9. doi: 10.1038/nature14098. Epub 2015 Jan 7. Erratum in: Nature. 2015 Apr 16;520(7547):388.

PMID:
25561178
5.

Teixobactin, the first of a new class of antibiotics discovered by iChip technology?

Piddock LJ.

J Antimicrob Chemother. 2015 Oct;70(10):2679-80. doi: 10.1093/jac/dkv175. Epub 2015 Jun 18. Review.

PMID:
26089440
6.

Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.

Katayama Y, Sekine M, Hishinuma T, Aiba Y, Hiramatsu K.

Antimicrob Agents Chemother. 2016 May 23;60(6):3730-42. doi: 10.1128/AAC.00420-16. Print 2016 Jun.

7.

Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.

Cui L, Iwamoto A, Lian JQ, Neoh HM, Maruyama T, Horikawa Y, Hiramatsu K.

Antimicrob Agents Chemother. 2006 Feb;50(2):428-38.

8.
9.

Comparative proteomic analysis of Staphylococcus aureus strains with differences in resistance to the cell wall-targeting antibiotic vancomycin.

Pieper R, Gatlin-Bunai CL, Mongodin EF, Parmar PP, Huang ST, Clark DJ, Fleischmann RD, Gill SR, Peterson SN.

Proteomics. 2006 Aug;6(15):4246-58.

PMID:
16826566
10.
11.
12.

Proton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activity.

Biswas R, Martinez RE, Göhring N, Schlag M, Josten M, Xia G, Hegler F, Gekeler C, Gleske AK, Götz F, Sahl HG, Kappler A, Peschel A.

PLoS One. 2012;7(7):e41415. doi: 10.1371/journal.pone.0041415. Epub 2012 Jul 23.

13.

Synthesis and biological evaluation of novel teixobactin analogues.

Schumacher CE, Harris PWR, Ding XB, Krause B, Wright TH, Cook GM, Furkert DP, Brimble MA.

Org Biomol Chem. 2017 Oct 25;15(41):8755-8760. doi: 10.1039/c7ob02169k.

PMID:
28993827
14.

Impact of antibiotics with various target sites on the metabolome of Staphylococcus aureus.

Dörries K, Schlueter R, Lalk M.

Antimicrob Agents Chemother. 2014 Dec;58(12):7151-63. doi: 10.1128/AAC.03104-14. Epub 2014 Sep 15.

15.

Discovery of potent wall teichoic acid early stage inhibitors.

Labroli MA, Caldwell JP, Yang C, Lee SH, Wang H, Koseoglu S, Mann P, Yang SW, Xiao J, Garlisi CG, Tan C, Roemer T, Su J.

Bioorg Med Chem Lett. 2016 Aug 15;26(16):3999-4002. doi: 10.1016/j.bmcl.2016.06.090. Epub 2016 Jun 30.

PMID:
27436582
16.

Autolysis control hypotheses for tolerance to wall antibiotics.

Koch AL.

Antimicrob Agents Chemother. 2001 Oct;45(10):2671-5. No abstract available.

17.

[Influence of Polycations on Antibacterial Activity of Lysostaphin].

Kulikov SN, Khairullin RZ, Varlamov VP.

Prikl Biokhim Mikrobiol. 2015 Nov-Dec;51(6):610-5. Russian.

PMID:
26859963
18.

An antibiotic that inhibits a late step in wall teichoic acid biosynthesis induces the cell wall stress stimulon in Staphylococcus aureus.

Campbell J, Singh AK, Swoboda JG, Gilmore MS, Wilkinson BJ, Walker S.

Antimicrob Agents Chemother. 2012 Apr;56(4):1810-20. doi: 10.1128/AAC.05938-11. Epub 2012 Jan 30.

19.

Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation.

Bertsche U, Weidenmaier C, Kuehner D, Yang SJ, Baur S, Wanner S, Francois P, Schrenzel J, Yeaman MR, Bayer AS.

Antimicrob Agents Chemother. 2011 Aug;55(8):3922-8. doi: 10.1128/AAC.01226-10. Epub 2011 May 23.

Supplemental Content

Support Center